Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
J Gen Intern Med. 2019 Jun;34(6):871-877. doi: 10.1007/s11606-018-4807-x. Epub 2019 Jan 10.
Components of substance use disorder (SUD) treatment have been shown to reduce inpatient and emergency department (ED) utilization. However, integrated treatment using pharmacotherapy and recovery coaches in primary care has not been studied.
To determine whether integrated addiction treatment in primary care reduces inpatient and ED utilization and improves outpatient engagement.
A retrospective cohort study comparing patients in practices with and without integrated addiction treatment including pharmacotherapy and recovery coaching during a staggered roll-out period.
A propensity score matched sample of 2706 adult primary care patients (1353 matched pairs from intervention and control practices) with a SUD diagnosis code, excluding cannabis or tobacco only, matched on baseline utilization.
A multi-modal strategy that included forming interdisciplinary teams of local champions, access to addiction pharmacotherapy, counseling, and recovery coaching. Control practices could refer patients to an addiction treatment clinic offering pharmacotherapy and behavioral interventions.
The number of inpatient admissions, hospital bed days, ED visits, and primary care visits.
During the follow-up period, there were fewer inpatient days among the intervention group (997 vs. 1096 days with a mean difference of 7.3 days per 100 patients, p = 0.03). The mean number of ED visits was lower for the intervention group (36.2 visits vs. 42.9 per 100 patients, p = 0.005). There was no difference in the mean number of hospitalizations. The mean number of primary care visits was higher for the intervention group (317 visits vs. 270 visits per 100 patients, p < 0.001). Intervention practices had a greater increase in buprenorphine and naltrexone prescribing.
In a non-randomized retrospective cohort study, integrated addiction pharmacotherapy and recovery coaching in primary care resulted in fewer hospital days and ED visits for patients with SUD compared to similarly matched patients receiving care in practices without these services.
物质使用障碍(SUD)治疗的各个组成部分已被证明可减少住院和急诊部(ED)的就诊次数。然而,在初级保健中使用药物治疗和康复教练进行综合治疗尚未得到研究。
确定初级保健中综合成瘾治疗是否可减少住院和 ED 就诊次数并改善门诊就诊情况。
一项回顾性队列研究,比较了在 staggered roll-out 期间采用包括药物治疗和康复教练在内的综合成瘾治疗与未采用这些治疗的实践中的患者。
2706 名患有 SUD 诊断的成年初级保健患者(来自干预和对照实践的 1353 对匹配对)的倾向得分匹配样本,排除仅患有大麻或烟草的患者,且在基线利用方面相匹配。
一种多模式策略,包括组建由当地拥护者组成的跨学科团队,提供成瘾药物治疗、咨询和康复教练。对照实践可以将患者转介到提供药物治疗和行为干预的成瘾治疗诊所。
住院人数、住院天数、急诊就诊次数和初级保健就诊次数。
在随访期间,干预组的住院天数较少(997 天与 1096 天,平均差异为每 100 例患者 7.3 天,p=0.03)。干预组的急诊就诊次数较低(36.2 次就诊与每 100 例患者 42.9 次就诊,p=0.005)。住院次数无差异。干预组的初级保健就诊次数较高(317 次就诊与每 100 例患者 270 次就诊,p<0.001)。干预实践的丁丙诺啡和纳曲酮处方量有所增加。
在一项非随机回顾性队列研究中,与未接受这些服务的实践中接受治疗的具有 SUD 的患者相比,初级保健中综合成瘾药物治疗和康复教练可减少 SUD 患者的住院天数和 ED 就诊次数。